(Q43963798)

28 November 2017

title

Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron (English)

1 reference

28 November 2017

1 reference

Ferry-Dumazet H

1

1 reference

28 November 2017

Mamani-Matsuda M

2

1 reference

28 November 2017

Dupouy M

3

1 reference

28 November 2017

Belloc F

4

1 reference

28 November 2017

Thiolat D

5

1 reference

28 November 2017

Marit G

6

1 reference

28 November 2017

Arock M

7

1 reference

28 November 2017

Reiffers J

8

1 reference

28 November 2017

Mossalayi MD

9

1 reference

28 November 2017

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

708-715

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402404

28 November 2017

exact match

0 references

cites work

Nitric oxide-cyclic GMP signal transduction system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Molecular mechanisms and therapeutic strategies related to nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Iron-induced carcinogenesis: the role of redox regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Iron, asbestos, and carcinogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Flow cytometry study of human cyclin B1 and cyclin E expression in leukemic cell lines: cell cycle kinetics and cell localization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

The iron component of sodium nitroprusside blocks NMDA-induced glutamate accumulation and intracellular Ca2+ elevation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Sodium nitroprusside prevents chemical hypoxia-induced cell death through iron ions stimulating the activity of the Na+-Ca2+ exchanger in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Iron chelators induce apoptosis in proliferating cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402404

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402404

1 reference

Dimensions Publication ID

28 November 2017

1039171085

0 references

1 reference